![Paul Secrist](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Paul Secrist worked as a Director & Senior Principal Scientist at AstraZeneca Pharmaceuticals LP from 2011 to 2017.
He then worked as the Senior Vice President-Discovery Research at LifeMine Therapeutics, Inc. from 2018 to 2020.
Currently, he is the Chief Scientific Officer at Cyteir Therapeutics, Inc. from 2020 to 2023.
Dr. Secrist completed his undergraduate degree at Wartburg College and his doctorate at Mayo Clinic College of Medicine & Science.
Former positions of Paul Secrist
Companies | Position | End |
---|---|---|
CYTEIR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2023 |
LifeMine Therapeutics, Inc.
![]() LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/06/2020 |
AstraZeneca Pharmaceuticals LP
![]() AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Chief Tech/Sci/R&D Officer | 01/12/2017 |
Training of Paul Secrist
Wartburg College | Undergraduate Degree |
Mayo Clinic College of Medicine & Science | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Cyteir Therapeutics, Inc.
![]() Cyteir Therapeutics, Inc. BiotechnologyHealth Technology Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA. | Health Technology |
LifeMine Therapeutics, Inc.
![]() LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Health Technology |
AstraZeneca Pharmaceuticals LP
![]() AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
- Stock Market
- Insiders
- Paul Secrist